NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The new Federal Reserve chair will step in as the world’s most powerful central bank faces scrutiny over interest rates and rising prices affecting Americans.Read More